U.S. markets closed

  • S&P 500

    4,682.85
    +33.58 (+0.72%)
     

  • Dow 30

    36,100.31
    +179.11 (+0.50%)
     

  • Nasdaq

    15,860.96
    +156.66 (+1.00%)
     

  • Russell 2000

    2,411.78
    +2.64 (+0.11%)
     

  • Crude Oil

    80.69
    -0.90 (-1.10%)
     

  • Gold

    1,867.70
    +3.80 (+0.20%)
     

  • Silver

    25.41
    +0.11 (+0.43%)
     

  • EUR/USD

    1.1446
    -0.0008 (-0.07%)
     

  • 10-Yr Bond

    1.5820
    +0.0220 (+1.41%)
     

  • GBP/USD

    1.3422
    +0.0056 (+0.42%)
     

  • USD/JPY

    113.8500
    -0.1960 (-0.17%)
     

  • BTC-USD

    63,623.78
    -1,342.61 (-2.07%)
     

  • CMC Crypto 200

    1,589.73
    -26.49 (-1.64%)
     

  • FTSE 100

    7,347.91
    -36.27 (-0.49%)
     

  • Nikkei 225

    29,609.97
    +332.07 (+1.13%)
     

At 6.4% CAGR, Asthma Spacer Market to Surpass US$ 2,523.1 Million, globally, by end of 2028, Says Coherent Market Insights (CMI)

Coherent Market Insights
·5 min read

SEATTLE, Nov. 12, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global asthma spacer market is estimated to be valued at US$ 1,637.5 million in 2021 and is expected to exhibit a CAGR of 6.4% during the forecast period (2021-2028).

Key Trends and Analysis of the Global Asthma Spacer Market:

Key trends in the market include initiatives by the various governments and healthcare organizations to raise knowledge regarding respiratory illnesses, as well as preventive and therapeutic treatments are having a beneficial influence on the demand for asthma spacers. For instance, in May 2021, according to the British Lung Foundation, preventer inhalers should be taken on a daily basis to help prevent attacks and control symptoms. Reliever inhalers, which operate by expanding the airways should only be used to relieve symptoms as they occur.

Increasing prevalence of asthma is estimated to propel the global asthma spacer market growth during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), around 25 million Americans were suffering from asthma and 3,524 died from asthma, in 2019. It is the most common chronic condition among American children, where one child out of every 12 has asthma.

Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/3020

Key Market Takeaways:

The global asthma spacer market is expected to exhibit a CAGR of 6.4% during the forecast period owing to key companies operating in the asthma spacers market are focusing on organic and inorganic growth strategies such as product launches and product approvals. For instance, in February 2018, Medical Developments International Ltd, an Australian healthcare equipment company, had released a new anti-static version of the Space Chamber Plus. The new type spacer is intended to deliver medicine to the lungs more effectively.

Among spacer type, volumatic segment is expected to witness highest CAGR in the global asthma spacer market during the forecast period, owing to it successful role in administration of proper amount of medication. Volumatic spacer enables the proper dosage to be inhaled slowly and accurately. Volumatic spacer permits the asthma medicine to efficiently reach at the lungs. Volumatic spacer is effective and minimizes the medication's adverse effects in the mouth. Lupin Ltd. and GlaxoSmithKline are the major key players involved in the volumatic spacer.

Based on distribution channel, retail pharmacy is estimated to expand at a fastest CAGR in the global asthma spacer market during the forecast period, due to the increasing number of distribution agreements with retail or independent pharmacies by market key players leads to the increase in over-the-counter sales of asthma spacers. For instance, in April 2017, Medical Developments International Limited, a pharmaceutical company, announced that it finalized ‘Ranging’ deals with Costco, Price Chopper and Independent Pharmacy Co-Op for the distribution of its range of ‘Compact Anti-Static Space Chamber’ respiratory devices in the U.S.

Among regions, Asia Pacific is expected to witness highest CAGR in the global asthma spacer market over the forecast period, owing to owing to increasing product launch of asthma spacers in the region. For instance, in April 2019, Cipla announced the launch of its inhaler Niveoli in India. Niveoli inhaler is India’s first extra-fine particle Beclomethasone-Formoterol combination Hydrofluoroalkane (HFA) inhaler for adults. Inhaler Niveoli is indicated for treatment of obstructive airway diseases such as asthma.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3020

Competitive Landscape:

Key players operating in the global asthma spacer market include Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, Lupin, GlaxoSmithKline Plc., Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke international Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS.

Market Segmentation:

  • Global Asthma Spacer Market, By Spacer Type:

    • Volumatic

    • Aerochamber

    • InspirEase

    • Optichamber

    • Others

  • Global Asthma Spacer Market, By Distribution Channel:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

  • Global Asthma Spacer Market, By Region:

    • North America

      • By Country

        • U.S.

        • Canada

    • Latin America

      • By Country

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • By Country

        • Germany

        • U.K.

        • France

        • Italy

        • Spain

        • Russia

        • Rest of Europe

    • Asia Pacific

      • By Country

        • China

        • India

        • Japan

        • Australia

        • South Korea

        • ASEAN

        • Rest of Asia Pacific

    • Middle East

      • By Country

        • GCC

        • Israel

        • Rest of Middle East

    • Africa

      • By Country/Region

        • South Africa

        • Central Africa

        • North Africa

Related Market Intelligence Reports:

Interspinous Spacers Market, by Product Type (Static (Non-compressible Spacers) and Dynamic (Compressible Spacers), by Indication (Lumbar Spinal Stenosis and Degenerative Disc Diseases), by End User (Hospitals, Ambulatory Surgery Centers, and Orthopedic Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2019-2026

Drug-device Combination Products Market, by Product Type (Drug Eluting Stents (Coronary Stent, and Peripheral Vascular Stents), Infusion Pumps (Implantable and Ambulatory), Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers (Dry Powder Inhaler, Nebulizers, and Metered Dose Inhaler)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027


About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Follow Us: LinkedIn | Twitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com


Recommended Stories

  • Warren Buffett just poured another $7.6 billion into his all-time favorite business — here are 3 other companies doing something very similar

    Buffett is betting big on his favorite company. It might be time to follow suit.

  • Why Shopify Stock Soared to a New All-Time High Today

    Shares of Shopify (NYSE: SHOP) surged 12% to a record closing high of $1,669.52 on Thursday as investors' enthusiasm for the e-commerce leader reached a fevered pitch. Shopify's third-quarter revenue rocketed 46% year over year to $1.1 billion. "Our results show that Shopify is executing well, giving our merchants the tools they need to compete in differentiated ways in a growing number of markets," Chief Financial Officer Amy Shapero said in the company's earnings release.

  • Why Shares of Fortuna Silver Mines Are Plunging Today

    While the price of silver is up nearly 6% so far in November, investors aren't recognizing Fortuna Silver Mines (NYSE: FSM) as a very lustrous option today. Investors are deciding to sell shares today as doubt surrounding the continuing operation of the company's core silver and gold asset located in Mexico, San Jose, increases. Concurrently, an analyst's bearish take on the stock is providing further motivation for investors to exit their positions.

  • Why Sundial Growers Stock Is Crushing It Today

    Shares of the Canadian pot-giant Sundial Growers (NASDAQ: SNDL) jumped by as much as 35% in pre-market trading Friday morning. After the closing bell Thursday afternoon, Sundial released its 2021 third-quarter earnings report. While the company posted net earnings of $11.3 million in Canadian dollars for the three-month period, this positive financial development doesn't appear to be what's truly moving the stock this morning.

  • Why Celsius Holdings Stock Is Down 19% This Week

    The Swedish maker of health-conscious energy drinks is sliding down from last week's all-time highs. A mixed earnings report didn't exactly help.

  • Is Now the Time to Buy AT&T Stock?

    Share prices of AT&T (NYSE: T) hit a 52-week low of $24.54 on Nov. 4 after the company delayed the rollout of its C-band spectrum, a component of its new 5G network, pending an aviation safety review. CEO John Stankey, who took over the top spot last year, is returning AT&T to its telco roots after his predecessor ventured into a number of expensive, entertainment-related acquisitions. A key reason to consider AT&T stock is its wireless business, which has experienced strong growth.

  • Why QuantumScape Stock Is Firing Up This Week

    With several electric-vehicle (EV) stocks charging up this week, QuantumScape (NYSE: QS) couldn't be left far behind. Shares of the EV battery technology company had shot up 23.6% this week as of 1:30 p.m. EST Friday, according to data from S&P Global Market Intelligence. The passage of a long-awaited infrastructure bill and growth moves from QuantumScape this week powered the stock higher.

  • Here's Why Palantir Stock Is Down Big This Week

    After the recent pullback, the big data specialist's stock is now down roughly 3.5% year to date.

  • Why AstraZeneca Stock Is Sinking Today

    What happened Shares of AstraZeneca (NASDAQ: AZN) were down by 6.9% as of 1:52 p.m. EST Friday after the big drugmaker announced its third-quarter results. AstraZeneca reported revenue of $9.9 billion for the quarter.

  • 3 Dividend-Paying Tech Stocks to Buy Right Now

    The recent spin-off of its managed infrastructure business into a company called Kyndryl (NYSE: KD) removes a noncore business from its balance sheet. Also, management promised that the two companies would maintain the current combined dividend.

  • Why The Trade Desk Stock Is Skyrocketing This Week

    The company crushed Wall Street's estimates on Monday, and many analysts praised the performance the next day.

  • Doubting that we could be in a stock-market bubble? Here’s the chart you need to see.

    Our call of the day from JonesTrading's chief strategist Michael O'Rourke says investors are ignoring history and a stock-market bubble that's bound to burst.

  • Volatility Spiked in the Cryptocurrency Mining Space This Week -- Here's Why

    This week was a rather volatile one for the investors in cryptocurrency miners. U.S.-based Riot Blockchain (NASDAQ: RIOT) has performed better than its peers, posting weekly intraday highs of nearly 40% this week, from last Friday's close. Rival Canaan (NASDAQ: CAN) also had a solid week, trading 23% higher at its peak this week compared to last, with SOS Limited (NYSE: SOS) coming in as the laggard, down approximately 30% on a week-over-week basis.

  • Musk Throws Fresh Shade at Rivian a Day After Rival’s Big IPO

    (Bloomberg) -- Elon Musk doesn’t exactly sound optimistic about the prospects of Rivian Automotive Inc., even after the rival electric-vehicle maker’s blockbuster IP0.Most Read from BloombergWhy Hong Kong Is Building Apartments the Size of Parking SpacesFarmers Take on ‘Post-Apocalyptic’ Food CrisisHong Kong's New Museum Tries to Please Art World — and BeijingGreece’s Popular Islands Are Crowded — With PlasticTesla Inc.’s chief executive officer said he hopes Rivian can boost production rates an

  • NIO's (NYSE:NIO) Road to High Margins is Paved With Dilutive Intentions

    After a breakthrough in 2020, NIO Inc.(NYSE: NIO)hit the roadblock in 2021, with periods of extreme volatility – typical for a high growth stock in a dynamic environment. While the EV market has been like a tide, lifting everything in the path, eventually, that tide will have to go out. Only then, as Warren Buffett famously said, we will discover who's been swimming naked.

  • 2 Unstoppable Stocks You Can Buy and Forget About

    If you want to beat the S&P 500, a good place to start is with stocks that are proven winners. Here are two.

  • Is Shopify Stock A Buy? SHOP Stock Surges In Heavy Volume

    Shopify, the upstart challenging eBay and Amazon.com, is now generating more than $1 billion in quarterly sales. On Oct. 28, Shopify earnings missed third-quarter estimates, but shares reversed sharply higher in heavy volume. What Is Shopify And How Does It Work?

  • Why Canopy Growth Shares Are Trading Higher Today

    Canopy Growth Corp (NASDAQ: CGC) is trading higher Friday on continued legalization hopes amid a Republican-leg marijuana legalization bill. The stock is also moving in sympathy with Sundial Growers Inc (NASDAQ: SNDL), which reported its third-quarter financial results and announced a share repurchase program. Sundial reported quarterly net earnings of $11.3 million Canadian dollars ($8.99 million), which is up from a loss of CAD$71.4 million year-over-year. The company reported quarterly adjust

  • Inovio Stock at $35 a Share? This Analyst Thinks It’s Possible

    Remember Inovio (INO), the small biotech punching above its weight and mingling with pharma giants in the early attempts to stamp out the Covid-19 pandemic? The company was one of the frontrunners in the race to bring a Covid vaccine to market, but that was eons ago in stock market terms with the stock only trending in one direction (down) since mid-2020’s improbable peaks. Inovio has struggled to get its Covid-19 DNA vaccine INO-4800 beyond the mid-stage of testing (at least in the US), and in

  • Breaking up isn’t hard to do: GE’s split unravels a massive management mistake

    The breakup of General Electric puts the final nail in the coffin of the corporate conglomerate business model, writes Jeffrey Sonnenfeld.